![](https://privsource-prod.s3.amazonaws.com/gpqrbdan43tm77wabs6y9a6tvkl3?response-content-disposition=inline%3B%20filename%3D%22qhp.png%22%3B%20filename%2A%3DUTF-8%27%27qhp.png&response-content-type=image%2Fpng&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIA6NYHEBQEVFIPN3SJ%2F20240727%2Fus-east-1%2Fs3%2Faws4_request&X-Amz-Date=20240727T044324Z&X-Amz-Expires=300&X-Amz-SignedHeaders=host&X-Amz-Signature=6e6e740023a196b1369cd1ecf647949039cf4b3ff426d4b356c8eb1bcae374a7)
QHP Capital Invests in Bend Bioscience
10.11.2022
Bend Bioscience, located in Bend, Oregon, is an early-phase Contract Development and Manufacturing Organization (CDMO) with an emphasis on drug delivery R&D partnerships, product development, and early phase manufacturing for enhanced formulations utilizing particle engineering-based drug delivery technologies.
The Premium Lower and Middle Market M&A Platform
For full transactional data, join PrivSource today!
Apply →